Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCatherine C. Coombs, Michael F. Berger, Ahmet Zehir et al.|Cell stem cell|2017Cited by 851
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseRobert R. Jenq, Marcel R.M. van den Brink, Sergio Giralt et al.|Biology of Blood and Marrow Transplantation|2015Cited by 762
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, João B. Xavier, Antonio L. C. Gomes et al.|New England Journal of Medicine|2020Cited by 739
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L. Bolton, Dean F. Bajorin, Ryan Ptashkin et al.|Nature Genetics|2020Cited by 739
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Yasuhito Nannya et al.|Nature Medicine|2020Cited by 633